Oriental Unicorn Agricultural Group Ltd reports 140% Net Income growth and 31.1 pp EBITDA Margin growth from -10.1% to 21.0%
21/03/2016 • About Oriental Unicorn Agricultural Group Ltd (
$8120) • By InTwits
Oriental Unicorn Agricultural Group Ltd reported FY2015 financial results today. Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.
Oriental Unicorn Agricultural Group Ltd ($8120) key annual financial indicators
| mln. | 2011 | 2012 | 2013 | 2014 | 2015 | 2015/2014 |
|---|
P&L
|
|---|
| Revenue | 86.3 | 112.4 | 24.6 | 28.7 | 57.7 | 100.8% |
| Gross Profit | 15.0 | 22.8 | -1.8 | 19.0 | 21.8 | 14.6% |
| SG&A | | | 36.5 | 29.2 | 19.7 | -32.4% |
| EBITDA | 6.0 | 14.1 | -20.2 | -2.9 | 12.1 | -519.7% |
| Net Income | 36.3 | 64.1 | -40.1 | -15.3 | 6.2 | -140.3% |
Balance Sheet
|
|---|
| Cash | 10.8 | 20.6 | 37.8 | 119.9 | 69.6 | -42.0% |
| Short Term Debt | 120.2 | 3.7 | 3.8 | 5.9 | 0.0 | -100.0% |
| Long Term Debt | 0.0 | 9.0 | 0.0 | | 0.0 | |
Cash flow
|
|---|
| Capex | 13.7 | | | 1.3 | | -100.0% |
Ratios
|
|---|
| Revenue growth | 144.6% | 30.2% | -78.1% | 16.8% | 100.8% | |
| EBITDA growth | 38.0% | 134.6% | -242.6% | -85.7% | -519.7% | |
| Gross Margin | 17.4% | 20.3% | -7.2% | 66.1% | 37.7% | -28.4% |
| EBITDA Margin | 7.0% | 12.6% | -81.9% | -10.1% | 21.0% | 31.1% |
| Net Income Margin | 42.1% | 57.0% | -162.8% | -53.2% | 10.7% | 63.9% |
| SG&A, % of revenue | | | 148.4% | 101.6% | 34.2% | -67.4% |
| CAPEX, % of revenue | 15.9% | | | 4.4% | | -4.4% |
| ROIC | | 36.1% | -28.1% | | | 0.0% |
| ROE | | | -57.5% | -8.1% | 2.0% | 10.0% |
| Net Debt/EBITDA | 18.2x | -0.6x | | | -5.7x | -5.7x |
Revenue and profitability
The company's Revenue jumped on 101% in FY2015. Having declining revenue the company managed to increase EBITDA margin. EBITDA Margin jumped on 38.0 pp from -70.9% to -33.0% in 2015.
Gross Margin dropped on 28.4 pp from 66.1% to 37.7% in FY2015. SG&A as a % of Revenue dropped on 67.4 pp from 102% to 34.2% in FY2015.
Net Income marign jumped on 63.9 pp from -53.2% to 10.7% in FY2015.
Leverage (Debt)
The company paid down all the debt in FY2015. Cash dropped on 42.0% in FY2015.
Appendix 1: Peers in Pharmaceuticals
Below you can find Oriental Unicorn Agricultural Group Ltd benchmarking vs. other companies in Pharmaceuticals industry. It's shown for the period of 5 years for the key financial metrics. Each table has median value for all the companies in the industry together with individual financial data of the top-5 companies in the industry by particular financial metric.
Top companies by Revenue growth, %
| Top 5 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|
| Hong Kong Life Sciences and Technology Group Ltd ($8085) | | -10.0% | -45.4% | 1,636.5% | -52.9% |
| Northeast Tiger Pharmaceutical Corp Ltd ($8197) | | 15.1% | -99.9% | 480.0% | -93.1% |
| United Gene High-Tech Group Ltd ($399) | | -71.8% | -60.5% | 196.0% | 14.2% |
| China Traditional Chinese Medicine Co Ltd ($570) | 3.1% | 22.3% | 35.2% | 90.0% | |
| Dragonite International Ltd ($329) | -8.8% | -10.5% | 13.5% | 64.8% | |
| |
|---|
| Median (41 companies) | 18.0% | 13.4% | 13.5% | 15.7% | 7.6% |
|---|
| Oriental Unicorn Agricultural Group Ltd ($8120) | | 30.2% | -78.1% | 16.8% | 100.8% |
Top companies by Gross margin, %
| Top 5 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|
| Jilin Province Huinan Changlong Bio-pharmacy Co Ltd ($8049) | 83.9% | 82.0% | 81.5% | 80.9% | |
| Consun Pharmaceutical Group Ltd ($1681) | 75.5% | 75.7% | 79.1% | 78.3% | |
| Sino Biopharmaceutical Ltd ($1177) | 78.5% | 78.5% | 77.5% | 76.4% | |
| China Health Group Inc ($8225) | 38.7% | 43.4% | 33.6% | 76.2% | 75.7% |
| Hua Han Bio-Pharmaceutical Holdings Ltd ($587) | 72.6% | 65.2% | 77.9% | 72.1% | 68.7% |
| |
|---|
| Median (39 companies) | 38.3% | 39.2% | 37.8% | 48.3% | 49.4% |
|---|
| Oriental Unicorn Agricultural Group Ltd ($8120) | 17.4% | 20.3% | -7.2% | 66.1% | 37.7% |
Top companies by EBITDA margin, %
| Top 5 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|
| Asia Resources Holdings Ltd ($899) | 3.5% | -80.8% | 25.1% | 113.7% | |
| Sihuan Pharmaceutical Holdings Group Ltd ($460) | 48.4% | 38.8% | 65.4% | 70.9% | |
| Pak Fah Yeow International Ltd ($239) | 28.7% | 33.9% | 28.4% | 52.4% | |
| Beijing Tong Ren Tang Chinese Medicine Co Ltd ($8138) | 29.7% | 41.3% | 45.4% | 47.5% | 49.1% |
| Real Nutriceutical Group Ltd ($2010) | 45.6% | 42.8% | 43.4% | 46.0% | |
| |
|---|
| Median (40 companies) | 17.7% | 20.3% | 20.2% | 21.4% | 17.7% |
|---|
| Oriental Unicorn Agricultural Group Ltd ($8120) | 7.0% | 12.6% | -81.9% | -10.1% | 21.0% |
Top companies by CAPEX/Revenue, %
| Top 5 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|
| Northeast Tiger Pharmaceutical Corp Ltd ($8197) | 0.2% | | 11,100.0% | 103.4% | 0.0% |
| Extrawell Pharmaceutical Holdings Ltd ($858) | 5.7% | 1.7% | 20.6% | 92.4% | 3.6% |
| Asia Resources Holdings Ltd ($899) | 12.2% | 4.4% | 8.1% | 92.0% | |
| Lijun International Pharmaceutical Holding Co Ltd ($2005) | 19.5% | 16.8% | 52.4% | 39.6% | |
| Hao Wen Holdings Ltd ($8019) | 6.4% | 30.0% | 2.3% | 38.2% | |
| |
|---|
| Median (40 companies) | 9.4% | 8.3% | 8.1% | 7.5% | 2.9% |
|---|
| Oriental Unicorn Agricultural Group Ltd ($8120) | 15.9% | | | 4.4% | |
Top companies by ROIC, %
| Top 5 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|
| Jilin Province Huinan Changlong Bio-pharmacy Co Ltd ($8049) | 18.5% | 16.7% | 20.8% | 33.0% | |
| Sino Biopharmaceutical Ltd ($1177) | 19.9% | 26.2% | 26.8% | 26.5% | |
| Beijing Tong Ren Tang Chinese Medicine Co Ltd ($8138) | | 25.3% | 27.5% | 23.8% | 25.9% |
| Lee's Pharmaceutical Holdings Ltd ($950) | 31.3% | 26.1% | 22.0% | 22.4% | |
| Sihuan Pharmaceutical Holdings Group Ltd ($460) | 14.3% | 13.7% | 18.3% | 22.0% | |
| |
|---|
| Median (41 companies) | 8.7% | 12.2% | 9.3% | 11.1% | 6.7% |
|---|
| Oriental Unicorn Agricultural Group Ltd ($8120) | | 36.1% | -28.1% | | |
Top companies by Net Debt / EBITDA
| Top 5 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|
| China NT Pharma Group Co Ltd ($1011) | 0.4x | | | 7.2x | |
| United Laboratories International Holdings Ltd/The ($3933) | 4.4x | 6.5x | 4.6x | 4.2x | |
| Lansen Pharmaceutical Holdings Ltd ($503) | 0.9x | 1.7x | 2.8x | 3.4x | |
| China Grand Pharmaceutical and Healthcare Holdings Ltd ($512) | 2.5x | 5.4x | 4.0x | 3.4x | |
| Shandong Xinhua Pharmaceutical Co Ltd ($719) | 1.4x | 3.5x | 3.4x | 2.8x | |
| |
|---|
| Median (34 companies) | -0.8x | -0.2x | -0.5x | -0.6x | -1.6x |
|---|
